| Name | Title | Contact Details |
|---|---|---|
Gaby Alves |
Chief Financial Officer | Profile |
As a locally owned, locally operated, not-for-profit hospital, Yavapai Regional Medical Center relies on patient revenues and community support for its funding. Since being incorporated in April 1942, Yavapai Regional Medical Center – the Prescott area’s community hospital – has seen a lot of change. What started as a simple, small-town hospital in the old Jefferson School building on Marina Street is today a state-of-the-art hospital system with two campuses, one in Prescott and one in Prescott Valley, and an ever-growing selection of high-quality programs and services, all designed to meet the healthcare needs of our communities. Growth and positive change are a familiar fact of life at YRMC, but what has not changed – and will never change – is the comfort we offer and the compassion we feel. These will forever remain. The cornerstone of the 21st century Yavapai Regional Medical Center is a Healing Team led by a community-based board of trustees, a trusted group of experienced administrators and the scores of concerned physicians in multiple specialties who form the YRMC Medical Staff. Complementing this outstanding leadership are the skills, training and competence of hundreds of professional nurses, therapists, technicians, support personnel and volunteers. But that’s just the beginning of the YRMC story.
Careplus Health Plans Inc is a Miami, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Blistex Inc. is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Oak Brook, IL. To find more information about Blistex Inc., please visit www.blistex.com
Restore Hyper Wellness is the award-winning creator of an innovative new category of care—Hyper Wellness®. Restore delivers expert guidance and an extensive array of cutting-edge health modalities, such as IV drips and cryotherapy, integrated under one roof. These modalities help you feel your best, so you can do more of what you love. With 120+ locations across 34+ states and a fast-growing national retail footprint, Restore makes proactive health more accessible than ever.
Assembly Biosciences (NASDAQ: ASMB) is a clinical-stage biotechnology company developing innovative therapeutics targeting hepatitis B virus (HBV) and diseases associated with the microbiome. The HBV program is focused on advancing a new class of potent, oral core inhibitors that have the potential to increase cure rates for chronically infected patients. The microbiome program is developing novel oral live microbial biotherapeutic candidates with Assembly`s fully integrated platform, including a robust process for strain identification and selection, GMP banking and production, and targeted delivery to the lower gastrointestinal tract with the GEMICEL® technology. We pride ourselves on creating a culture and work environment that is scientifically driven, ambitious, and collaborative. We encourage diversity of thought that leads to great innovation and are looking to add to our dynamic team great people who are driven to transform the lives of patients. We believe our Microbiome platform represents a best in class approach to developing biopharmaceutical agents from live biotherapeutic products. ABI-M201, our lead program in mildly to moderately active ulcerative colitis (UC), is currently in a phase 1b clinical trial. This program is part of a broader collaboration we established with Allergan in 2017 for gastrointestinal programs such as UC, Crohn`s disease and Irritable Bowel Syndromes with potential total development and commercial milestones of up to $2.8 billion. Our internal pipeline comprises first in class or best in class live microbial biotherapeutic approaches in areas such as oncology, immune mediated and metabolic disorders, and other areas of high medical need. Assembly is headquartered in Carmel, Indiana, while the R&D headquarters is in South San Francisco. The Company also has a microbiome manufacturing facility in Groton, CT, and offices in China.